Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-01-69
NCT00047515 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL
Last updated 2008-08-05
Summary
To compare intraocular pressure lowering effectiveness of a combination drug vs. two individual drugs dosed alone.
Conditions
- Open-Angle Glaucoma
- Ocular Hypertension
Interventions
- DRUG
-
Alcon Investigational Agent
Sponsors & Collaborators
-
Alcon Research
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2001-01-31
- Primary Completion
- 2003-12-31
- Completion
- 2003-12-31
Countries
- United States
More Related Trials
-
A Study of Patients With Primary Open Angle Glaucoma or Ocular Hypertension Who Were Insufficiently Responsive to Monotherapy
NCT01637246 ·Status: COMPLETED
-
A 12-Month Study to Evaluate the Efficacy and Safety of Once-Daily Instillation of Combination Glaucoma Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension
NCT00311389 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
NCT00287521 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase III Study of Brimonidine Tartrate Ophthalmic Solution, 0.15% in Patients With Open-Angle Glaucoma or Ocular Hypertension
NCT00061529 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
NCT00333125 ·Status: COMPLETED ·Phase: PHASE3
-
Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-angle Glaucoma or Ocular Hypertension Patients
NCT00069706 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
NCT00314158 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
NCT00326092 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase III Study of Travoprost/Timolol Combination in Patients With Open-Angle Glaucoma or Ocular Hypertension
NCT00672997 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Intraocular Pressure (IOP) Lowering Effect of AL-59412C
NCT01312454 ·Status: TERMINATED ·Phase: PHASE2
-
Phase III Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients
NCT00288951 ·Status: COMPLETED ·Phase: PHASE3
-
24 Hour IOP Lowering Efficacy of AL-3789
NCT00643669 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase II Study of AL-37807 to Treat Open-Angle Glaucoma or Ocular Hypertension
NCT00372931 ·Status: COMPLETED ·Phase: PHASE2
-
Patient Preference Study
NCT00576342 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of the Alpha-2 Agonists for Prevention of Intraocular Pressure Elevation After Selective Laser Trabeculoplasty
NCT00567411 ·Status: UNKNOWN ·Phase: NA
-
A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
NCT00314171 ·Status: COMPLETED ·Phase: PHASE3
-
The Diurnal and Nocturnal Effect of Pilocarpine on Intraocular Pressure and Ocular Perfusion Pressure
NCT02754570 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension
NCT01241240 ·Status: COMPLETED ·Phase: PHASE3
-
Study of SHP639 Eye Drops in Adults With High Eye Pressure or Primary Open-angle Glaucoma
NCT03131167 ·Status: COMPLETED ·Phase: PHASE1
-
Determination Of Predictive Factors Allowing To An Additional 10% Reduction Of Intra-Ocular Pressure
NCT00230763 ·Status: COMPLETED ·Phase: PHASE3
-
AL-54478 Proof of Concept Study
NCT01318252 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Comparing IOP-Lowering Treatments to Bimatoprost in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
NCT01646151 ·Status: COMPLETED
-
Phase 3 Trial of NCX 470 vs. Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension
NCT04445519 ·Status: COMPLETED ·Phase: PHASE3
-
A Dose-Volume Study of a Treatment for Elevated IOP Due to Open-Angle Glaucoma or Ocular Hypertension
NCT00788541 ·Status: TERMINATED ·Phase: PHASE2
-
24-hour IOP-lowering Effect of Brimonidine 0.1%
NCT00457795 ·Status: COMPLETED ·Phase: PHASE4